scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1154900Q |
P356 | DOI | 10.1371/JOURNAL.PONE.0154900 |
P932 | PMC publication ID | 4858273 |
P698 | PubMed publication ID | 27148878 |
P5875 | ResearchGate publication ID | 301932523 |
P50 | author | Eugenia Quiros-Roldan | Q30650722 |
Elena Raffetti | Q47710022 | ||
P2093 | author name string | Francesco Donato | |
Francesco Castelli | |||
Emanuele Focà | |||
Chiara Pezzoli | |||
Michele Magoni | |||
Alice Ferraresi | |||
Filippo Castelnuovo | |||
Nigritella Brianese | |||
P2860 | cites work | High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. | Q51555647 |
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. | Q51943315 | ||
Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. | Q53074863 | ||
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by | Q55037836 | ||
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Q57413870 | ||
Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation | Q59450174 | ||
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis | Q63915146 | ||
Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease | Q73155625 | ||
Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris | Q74182408 | ||
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study | Q79873289 | ||
HIV infection and the risk of acute myocardial infarction | Q27347231 | ||
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies | Q29615413 | ||
Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. | Q30301196 | ||
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study | Q30934548 | ||
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study | Q33602915 | ||
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses | Q33910496 | ||
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment | Q34315579 | ||
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 | ||
Consolidated and emerging inflammatory markers in coronary artery disease | Q35019922 | ||
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis | Q35182277 | ||
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction | Q35636087 | ||
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study. | Q36034748 | ||
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy | Q37492492 | ||
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force | Q37608837 | ||
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study | Q39377412 | ||
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study | Q40971969 | ||
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity | Q41454338 | ||
Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention | Q43709336 | ||
Blood Neutrophil to Lymphocyte Ratio as a Predictor of Hypertension | Q44884810 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | e0154900 | |
P577 | publication date | 2016-05-05 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study | |
P478 | volume | 11 |
Q88816367 | Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant |
Q55512944 | Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015. |
Q92696173 | Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study |
Q59811129 | Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis |
Q36309602 | Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort |
Search more.